Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4168274
Max Phase: Preclinical
Molecular Formula: C24H27N3O3
Molecular Weight: 405.50
Molecule Type: Small molecule
Associated Items:
ID: ALA4168274
Max Phase: Preclinical
Molecular Formula: C24H27N3O3
Molecular Weight: 405.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NC(=O)c1ccc(-n2cccc2Cc2ccccc2O)cc1N[C@H]1CC[C@H](O)CC1
Standard InChI: InChI=1S/C24H27N3O3/c25-24(30)21-12-9-19(15-22(21)26-17-7-10-20(28)11-8-17)27-13-3-5-18(27)14-16-4-1-2-6-23(16)29/h1-6,9,12-13,15,17,20,26,28-29H,7-8,10-11,14H2,(H2,25,30)/t17-,20-
Standard InChI Key: DAFDTRSWRWXFIR-IRJFHVNHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 405.50 | Molecular Weight (Monoisotopic): 405.2052 | AlogP: 3.59 | #Rotatable Bonds: 6 |
Polar Surface Area: 100.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.01 | CX Basic pKa: 3.06 | CX LogP: 3.87 | CX LogD: 3.87 |
Aromatic Rings: 3 | Heavy Atoms: 30 | QED Weighted: 0.50 | Np Likeness Score: -0.72 |
1. Jiang F, Guo AP, Xu JC, You QD, Xu XL.. (2018) Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis., 61 (21): [PMID:30351001] [10.1021/acs.jmedchem.8b00800] |
2. Li L, Wang L, You QD, Xu XL.. (2020) Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions., 63 (5): [PMID:31663736] [10.1021/acs.jmedchem.9b00940] |
3. Yu J, Zhang C, Song C.. (2022) Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances., 238 [PMID:35691175] [10.1016/j.ejmech.2022.114516] |
Source(1):